COMMUNIQUÉS West-GlobeNewswire

CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference

09/01/2019 - 13:25

LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the Benzinga Cannabis [...]

Resonant Inc. Adds New Filter IP Standard Library and 5G Information to Company Website

09/01/2019 - 13:05

Provides additional information on website for new Filter IP Standard Library, including roadmap Unveils XBAR 5G video GOLETA, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in [...]

Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director

09/01/2019 - 13:00

PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to [...]

Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study

09/01/2019 - 13:00

BUFFALO, N.Y., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility

09/01/2019 - 13:00

Agreement Provides Greater Financial Flexibility as Company Continues to Reduce Debt LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended [...]

Auxly Announces Completion of Inverell S.A. Acquisition

09/01/2019 - 13:00

VANCOUVER, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the " Company ") is pleased to announce that, further to its previous releases, it has completed the [...]

MediPharm Labs Announces Increased Management Shareholdings and Stock Option Grant

09/01/2019 - 12:31

TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF) (the “ Company ” or “ MediPharm Labs ”), a specialized, research-driven cannabis extraction business, fully licensed under the [...]

INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis

09/01/2019 - 12:00

Company’s Proprietary Formulation Continues to Show Promise as Potential Alternative to Intramuscular Injection PHOENIX, Jan. 09, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the [...]

Correction: Bilan Annuel du contrat de liquidité contracté par Eurobio Scientific avec Louis Capital Markets

09/01/2019 - 11:57

BILAN ANNUEL DU CONTRAT DE LIQUIDITE CONTRACTE PAR EUROBIO SCIENTIFIC AVEC LOUIS CAPITAL MARKETS Paris, le 7 janvier 2019 – 17h45 Au titre du contrat de liquidité portant sur les actions de la société Eurobio Scientific [...]

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation

09/01/2019 - 11:40

ORION CORPORATION STOCK EXCHANGE RELEASE 9 JANUARY 2019 at 12.40 EET Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation The Nomination Committee [...]

Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company Olainfarm

09/01/2019 - 11:35

Management Board of the Joint Stock Company Olainfarm (JSC Olainfarm), unitary registration number. 40003007246, registered address: Rupnicu iela 5, Olaine, LV-2114, announces that on January 08th, 2019, joint request [...]

De-listing and cancellation of trading of Shire Shares

09/01/2019 - 09:09

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]

Basilea reports positive interim results from registrational phase 2 study with oncology drug candidate derazantinib in intrahepatic cholangiocarcinoma (iCCA)

09/01/2019 - 07:16

21% objective response rate with six confirmed partial responses from 29 evaluable patients 83% disease control rate Safety profile and tolerability of continuous dosing schedule confirmed Basel, Switzerland, January 09 [...]

RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.

09/01/2019 - 07:00

Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical, 64 Cu-Dotatate, was granted [...]

Mesa's Board Announces Death of Board Member H. Stuart Campbell

09/01/2019 - 02:00

Lakewood, Colo., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that H. Stuart Campbell, Mesa’s Lead Independent Director has died at the [...]

Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09/01/2019 - 00:30

LAKE FOREST, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Akorn granted an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) pursuant to an employment [...]

Management Cease Trade Order Update

09/01/2019 - 00:00

HALIFAX, Nova Scotia, Jan. 08, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]

MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma

09/01/2019 - 00:00

LA JOLLA, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 16, 2019

08/01/2019 - 23:17

BURLINGTON, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham Growth Conference on Wednesday, January 16 [...]